Kestra Medical Technologies (KMTS) Gross Profit (2024 - 2026)
Kestra Medical Technologies (KMTS) has disclosed Gross Profit for 3 consecutive years, with $12.9 million as the latest value for Q1 2026.
- Quarterly Gross Profit rose 97.13% to $12.9 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $40.8 million through Jan 2026, up 127.07% year-over-year, with the annual reading at $24.2 million for FY2025, 6587.85% up from the prior year.
- Gross Profit for Q1 2026 was $12.9 million at Kestra Medical Technologies, up from $11.4 million in the prior quarter.
- The five-year high for Gross Profit was $12.9 million in Q1 2026, with the low at $880000.0 in Q1 2024.
- Average Gross Profit over 3 years is $6.6 million, with a median of $6.5 million recorded in 2025.
- Peak annual rise in Gross Profit hit 643.98% in 2025, while the deepest fall reached 95.95% in 2025.
- Over 3 years, Gross Profit stood at $5.8 million in 2024, then skyrocketed by 95.95% to $11.4 million in 2025, then grew by 12.97% to $12.9 million in 2026.
- According to Business Quant data, Gross Profit over the past three periods came in at $12.9 million, $11.4 million, and $8.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.